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Highlights 
 Among obese patients, bariatric surgery conferred a lower risk of heart failure 
 Heart failure was less than half of non-surgical obese patients 
 Bariatric surgery could prevent heart failure in the severely obese 
Abstract 
Background: Obesity is a known risk factor for heart failure. The prevalence of both 
conditions has increased in Sweden the last decades. Obesity surgery has been shown to 
improve cardiac function. We therefore investigated whether the risk of heart failure was 
lower in obese patients after bariatric surgery compared with obese patients without surgical 
intervention. 
Methods and results: From the Swedish National Patient Registry we created a cohort 
including 47,859 patients aged 18-74 years with a primary diagnosis of obesity from 2000 to 
2011. Of these, 22,295 (46.6%) underwent bariatric surgery (mean age 40.7 (standard 
deviation (SD) 10.7) years, 75.9% female). There were 25,564 (53.4%) non-surgical obese 
patients (mean age 44.3 (SD 13.2) years, 66.8% female). Patients who underwent bariatric 
surgery had a markedly reduced risk of heart failure compared with non-surgical obese 
patients (age and sex adjusted hazard ratio (HR) 0.37, 95% confidence interval (CI) 0.29-
0.46). The lower risk persisted after further adjustment for baseline differences in known risk 
factors for heart failure (HR 0.37, 95% CI 0.30-0.46). Conclusion: Patients who underwent 
bariatric surgery had a reduced risk of heart failure after surgery compared with non-surgical 
obese patients. 
 
Keywords: Heart failure, obesity, bariatric surgery, mortality, epidemiology 
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Introduction 
 Heart failure is a major public health problem, with an estimated lifetime risk of 1 in 5 
among men and women in the United States.
1
 The prevalence of heart failure is 
approximately 1–2% in the adult population in developed countries,2 and it is a leading cause 
of hospitalization, morbidity, and mortality among the older population (>65 years)
3
. Recent 
data indicate that the incidence of heart failure is increasing among people younger than 45 
years in Sweden.
4
 
 Obesity is increasingly being recognised as a major risk factor for heart failure.
5, 6
 A 
recent study demonstrated a strong association between adolescent body mass index (BMI) 
and early heart failure
7
 and indicated a potential association between the increased prevalence 
of obesity
8
 and rising rates of heart failure among younger individuals.
4, 9
 The prevalence of 
morbid obesity has more than doubled worldwide during the last few decades. In Sweden, the 
prevalence of obesity in 2013 was estimated at 19.8% in women and 18.9% in men at least 20 
years old.
10
 The effects of obesity on the cardiovascular system are likely partly mediated by 
increased blood pressure and increased levels of glucose and lipids.
11
 
 Bariatric surgery is currently the only available treatment with documented sustained 
weight loss and significant improvement or complete resolution of obesity-related 
comorbidities in morbidly obese patients.
12
 During the 2000s, gastric bypass became the most 
commonly performed procedure for bariatric surgery in Sweden and worldwide. Although the 
sleeve gastrectomy procedure rose in popularity during 2008 and is the most performed 
procedure in some countries,
13
 to date gastric bypass is still the most commonly performed 
procedure in Sweden.
14
 Bariatric surgery, and gastric bypass in particular, improve the 
prognosis for morbidly obese patients as these procedures decrease cardiovascular risk by 
improving blood pressure, blood lipid levels, and dysglycemia.
15, 16
 A report from the 
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Scandinavian Obesity Surgery registry (SOReg) showed that patients who had undergone 
bariatric surgery in Sweden from 2007 to 2012 had an average BMI of 45 when they 
underwent the operation. During the first year after surgery, their weight stabilised at an 
average BMI of around 32. After the procedure, the patients initially kept their weight stable 
and slowly started gaining weight 5 years later.
14
 Given the strong association between BMI 
and heart failure,
5
 this weight reduction should, in theory, decrease the risk of heart failure, as 
shown in a recent study where bariatric surgery patients were compared to a selected group of 
obese patients participating in an intervention program.
17
  
 In the present study, we aimed to test the hypothesis that the risk of hospitalization for 
heart failure and overall mortality would decrease among patients who have undergone 
bariatric surgery, compared with patients with an obesity diagnosis who have not undergone 
such surgery in a large cohort with long-term and near complete follow-up. 
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Methods 
Study design 
 In this nationwide observational Swedish cohort study, data from the Swedish National 
Patient Registry was used to obtain information about obesity diagnosis, comorbidities, and 
bariatric surgery. The Patient Registry includes records for all hospitalizations and specialist 
outpatient visits in Sweden since 2001, with complete data for principal and contributory 
discharge diagnoses for all patients since 1987.
16
 The registry, in general and for bariatric 
surgery and heart failure diagnosis specifically, has validity of 85–95% when compared with 
patient records.
16-18
 In addition, the Cause of Death Registry, which documents underlying 
causes of all deaths among Swedish residents, was linked with the Patient Registry through 
the Swedish 10-digit personal identification number to collect date and causes of death. All 
data were anonymized. The Regional Ethical Review Board in Stockholm approved this 
study.  
 
Study cohort 
 From the Patient Registry, we created a cohort that included all patients from 18 to 74 
years old with a first recorded principal diagnosis of obesity in Sweden. The International 
Classification of Disease (ICD) version 10, which has been used in Sweden since 1997, was 
used to identify patients with a principal diagnosis of obesity, defined by the codes E65, E66, 
or E68. The inclusion started at first recorded diagnosis of obesity between January 1, 2000 
and December 31, 2011. The patients were then followed up until the time of first hospital 
discharge with a heart failure diagnosis (principal or contributory), death, or the end of follow 
up (December 31, 2012), whichever occurred first. All patients with a prevalent diagnosis of 
heart failure (codes 428 for ICD9 and I50 for ICD10) at or prior to their obesity diagnosis was 
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excluded from the study (n=853). We also excluded patients who died on the same day that 
they were diagnosed with obesity (n=4). 
 The Swedish Classification of Operations and Major Procedures was used to identify 
patients who had undergone bariatric surgery: operation codes JDF00, JDF01 (vertical banded 
gastroplasty), JDF10, JDF11 (gastric bypass), JDF20, JDF21 (gastric banding), JFD03, and 
JFD04 (duodenal bypass). Two patients with bariatric surgery codes who did not have a 
principal diagnosis of obesity were excluded. In bariatric surgery patients who had an obesity 
diagnosis but the date of diagnosis was missing (n=67), the date of surgery was used as the 
inclusion date. For patients who had obtained their first principal diagnosis of obesity at the 
same day as their bariatric surgery, we used the secondary diagnosis of obesity closes in time 
prior to surgery. 
 
Definition of heart failure and comorbidities 
 The main outcome was first heart failure diagnosis in any position in the Patient 
Registry. We defined heart failure by the ICD10 code I50. Baseline comorbidities were 
defined as any of the following diagnoses prior to or concomitant with the index obesity 
diagnosis: hypertension (ICD9: 401–405; ICD10: I10–I15), diabetes (ICD9: 250; ICD10: 
E10–E14), sleep apnea (ICD9: 327.2, 780.5; ICD10: G47.3), coronary heart disease (ICD9: 
410-414; ICD10: I20–I25), malignancy (ICD9: 140–208; ICD10: C00–C97), myocardial 
infarction (ICD9: 410; ICD10: I21), atrial fibrillation (ICD9: 427D; ICD10: I48), stroke 
(ICD9: 431–434, 436; ICD10: I61–I64), valvular disease (ICD9: 394–398, 745–747; ICD10: 
I05–I09, I33–I39, Q20–Q28, Q87, Q89), or cardiomyopathy (ICD9: 425; ICD10: I42, I43). 
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Statistical analysis 
 Chi-square tests were used to determine differences in mean values between non-
surgical and surgical patients at obesity diagnosis and date of bariatric surgery. The absolute 
risk of heart failure and death were estimated and illustrated with a multi-state disease model 
(figure 1) where outcome is dependent on a patient’s previous health state. All patients started 
at the first state, obesity diagnosis, from there, the transition probability of moving from one 
state to another was estimated with two Cox proportional hazard regressions, to assess the 
relative risk of heart failure and mortality over time for obese surgical compared with obese 
non-surgical patients. The covariates in our first model were age and sex. In the second 
model, we added history of coronary heart disease, hypertension, and diabetes. Age was 
entered as a continuous variable in both models. In addition, we stratified the models by the 
age groups 18–44, 45–59, and 60–74, and comorbidity at baseline. The covariates satisfied 
the assumption of proportional hazards. 
 Incidence rates for heart failure and death were calculated as the ratio of events and 
person-years of follow-up for all patients. Person-time in the non-surgical group was 
calculated from obesity diagnosis until first event of bariatric surgery, heart failure, death or 
end of study. Person-time in the surgical group was calculated from date of bariatric surgery 
first event of heart failure, death, or end of study. The rates were calculated for the age groups 
18–44, 45–49, 50–54, 55–59, 60–64, 65–69, and 70–74 years, categorized from the age at 
obesity diagnosis. Survival probability for heart failure were estimated according to the 
Kaplan-Meier method. 
 All statistical analyses were performed using the statistical software SAS, version 9.4 
(SAS Institute, Cary, NC). 
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Results 
Baseline data 
 The study cohort included 47,859 patients from 18 to 74 years old with a principal 
diagnosis of obesity (mean age at obesity diagnosis 42.6 years; standard deviation (SD) 12.2 
years). Of these, 22,295 (46.6%) had bariatric surgery. The mean age at obesity diagnosis was 
40.7 (SD 10.7) years in the surgical group and 44.3 (SD 13.2) years in the non-surgical group 
(Table 1). Most patients were women (75.9% in the surgery group and 66.8% the non-surgery 
group). The median time from obesity diagnosis to bariatric surgery was 0.7 (interquartile 
range (IQR) 1.4) years. 
 Hypertension and diabetes were the most commonly recorded comorbidities as 26% of 
the men and 13.5% of the women had hypertension, and 16.8% and 9.3% respectively had 
diabetes at date of obesity diagnosis (Table 1). At the time of bariatric surgery 32.9% and 
18.1% of men and women, respectively, had hypertension and 23.2% and 12.3%, 
respectively, had diabetes (Supplementary table 1). At obesity diagnosis, 8.0% of the men had 
a recorded diagnosis of coronary heart disease, compared with 5.1% at the time of surgery. 
Few patients (<5%) in any of the groups had a recorded diagnosis of cancer, myocardial 
infarction, atrial fibrillation, stroke, congenital heart disease, valve disease, or 
cardiomyopathy (Table 1). 
 Of the surgical patients, 20,680 (92.8%) underwent gastric bypass surgery, and 84.1% 
of these had laparoscopic procedures. The remaining surgical patients underwent gastric 
banding (n=772, 3.5%), vertical banded gastroplasty (n=678, 3.0%), or gastro-duodenal 
bypass (n=165, 0.7%). 
 
Incidence of heart failure 
 There were 1033 patients hospitalized with heart failure, including 944 (3.7%) in the 
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non-surgical group and 89 (0.4%) in the surgical group. The median follow-up time for all 
cohort members from diagnosis of obesity to heart failure was 3.7 (IQR 3.2) years. The 
overall incidence rate of heart failure was 5 times higher among the non-surgical patients 
(6.9/1000 person-years, 95% CI 6.4–7.3), than among the surgical patients (1.0/1000 person-
years, 95% CI 0.8–1.3). The incidence rate increased with age in all participants, from 
1.5/1000 person-years (95% CI 1.2–1.8) to 39.9/1000 person-years (95% CI 32.6–47.4) 
among 18–44 and 70–74 year old non-surgical patients, respectively, and from 0.3/1000 
person-years (95% CI 0.1–0.4) to 10.6/1000 person-years (95% CI 1.3–19.9) among 18–44 
and 65–69 year old surgical patients, respectively (there were no cases in the oldest age 
group) (Table 2). 
 
Mortality rate 
 The median follow-up time from obesity diagnosis to death for the entire cohort was 
3.8 (IQR 3.2) years. There were 1189 (2.5%) deaths, 938 (3.7%) of which occurred among 
the non-surgical patients (5.5% of the men and 2.7% of the women) and 251 (1.1%) among 
the surgical patients (1.8% of the men and 0.9% of the women). Twenty-one of the surgical 
patients died within 30 days of operation due to obesity (n=17), unknown cause (n=2), 
incisional hernia (n=1), or myocardial infarction (n=1). The mortality rates were higher 
among the non-surgical patients (6.7/1000 person-years, 95% CI 6.3–7.1) than the surgical 
patients (2.9/1000 person-years, 95% CI 2.6–3.3) (Supplementary Table 2). 
 
Overall risk of heart failure and mortality 
 The risk of heart failure was lower among patients who underwent bariatric surgery 
compared with the obese patients who did not have such surgery (Figure 1). The age and sex 
adjusted Cox regression analysis showed a 63% lower risk of heart failure (HR 0.37, 95% CI 
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0.29–0.46). In the full model, which adjusted for baseline differences in known risk factors 
for heart failure, the decreased risk among the surgical patients remained unchanged (HR 
0.37, 95% CI 0.30–0.46). The decreased risk persisted in all age groups. Cases without known 
diabetes at baseline and who underwent bariatric surgery had the lowest risk of heart failure 
(HR 0.26, 95% CI 0.16–0.42). The risks for patients with hypertension or coronary heart 
disease were similar to those without these diseases at baseline (Figure 2).  
 The risk of overall mortality was lower among the surgical patients. The Cox 
regression analysis showed a 22% reduced risk of mortality (sex and age adjusted model: HR 
0.78, 95% CI 0.67–0.90; full model: 0.78, 95% CI 0.68–0.90) (Figure 2).  
 Overall, heart failure free survival 12 years after baseline was higher in the surgical 
group (Survival probability 0.98) compared to the surgical group (survival probability 0.93). 
The difference in survival started to deviate directly after baseline. 
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Discussion 
 In this nationwide Swedish cohort study, we found that patients who underwent 
bariatric surgery had substantially lower risk of developing heart failure and lower mortality 
compared with non-surgical obese patients. 
 The incidence of heart failure depends on the criteria used to define heart failure. 
Studies which included patients treated in primary care showed higher incidence rates than 
studies based on hospitalizations only.
21
 
22
 A recent study from our group, which included 
hospitalized cases only, found that heart failure rates were about 0.5 per 1000 person-years in 
persons aged 45–54.4 In the present study, we found rates that were 2–3 times higher, even in 
the bariatric surgery group. This indicates that the risk of developing heart failure in obese 
patients after bariatric surgery may still be substantially higher than in the general population. 
 One recent study which identified patients from the SOReg over the period 2007-2012 
and compared them with obese subjects participating in an intervention program showed that 
bariatric surgery patients had a 54% reduced risk of heart failure.
17
 Although based on a later 
inclusion period, the patients in the surgery group comprised the same patients as our study 
population for the corresponding years. The risk reduction was less marked than in our 
analysis, likely due to weight loss in the control population after participation in the 
intervention program, whereas the non-surgical obese in our study probably did not lose 
weight to the same extent. Accordingly, these two studies represent a continuum from non-
surgical obese, with weight loss that was likely minimal, to moderate weight loss with 
lifestyle intervention, and marked weight loss with surgery, and successively lower risk of 
heart failure, strengthening the causal role of obesity in the development of heart failure. 
Another study with long follow-up showed that bariatric surgery prevented cardiovascular 
events in surgical obese patients compared with non-surgical obese controls.
23
 This decrease 
in overall cardiovascular risk could be explained by an improvement in cardiac structure and 
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function through improvements in type 2 diabetes and hypertension.
24
 As these comorbidities 
are known risk factors for heart failure,
5
 it is a plausible explanation for the lower risk seen in 
the present study. Another potential explanation for this risk reduction is the decrease in body 
weight per se following bariatric surgery. Previous studies have demonstrated that an elevated 
BMI is associated with an increased risk of developing heart failure.
5, 6
 This is particularly 
true in younger individuals. Among 18-year-old males, those with BMI ≥35 had an almost 10-
fold increased risk for early heart failure compared with those with a BMI around 20.
7
 In 
addition, weight loss after bariatric surgery has been reported to reverse the disturbances in 
left ventricular function.
25
 We know from previous reports that surgical obese patients in 
Sweden during the time period for the present study lost a substantial amount of excess 
weight post-surgery,
14
 while we have good reason to believe that the weight of the non-
surgical obese patients remained stable.
26, 27
 
 Overall mortality was lower among those who underwent bariatric surgery compared 
with those who did not. This result is consistent with previous studies.
27, 28
 In addition, the 
absolute risk of mortality within one year of bariatric surgery has been found to be low,
29
 
which is consistent with this study. There were few deaths within 30 days after bariatric 
surgery. The inclusion of those deaths in the analysis did not change the risk estimates.  
 
Strengths and limitations 
 A major strength of this study was that we were able to include almost all patients in 
Sweden who underwent bariatric surgery during the study period. This provided a large study 
population and a long follow-up period (up to 12 years in some cases). Additionally, we were 
able to identify a similar group of patients with obesity as the primary diagnosis in the Patient 
Registry for comparison. The large number of heart failure cases, using complete and valid 
Swedish hospitalization data, is another advantage of this study.
18, 19
 Finally, we only included 
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patients with a primary diagnosis of obesity in this study, which was more likely to capture 
patients actively seeking help for their obesity or obesity related problems and not those who 
received their obesity diagnosis in conjunction with hospitalization for other conditions. If 
patients with secondary diagnosis of obesity were to be included, the cohort would include 
many patients who would never be considered for bariatric surgery due to their older age and 
sever comorbidity. 
 There are also a number of limitations, including the fact that we had no 
anthropometric data. However, these data are available from other studies.
14
 In the Swedish 
Obese Subjects (SOS) trial,
27
 surgical cases had a BMI of about 42 kg/m
2
, with about 2 units 
lower for non-surgical cases. Another limitation is the lack of information about the severity 
and type of heart failure, including echocardiography or ejection fraction, or whether the 
index hospitalisation was due to acute decompensated heart failure, or worsening of heart 
failure already diagnosed in a primary care setting. It could be hypothesized that the patients 
with an obesity diagnosis who underwent bariatric surgery were overall healthier and may 
have had less severe heart failure, which did not result in hospitalization, compared with other 
obese patients. In addition, patients underwent bariatric surgery when they were relatively 
young and few of them were at an age where heart failure usually occurs. Furthermore, even 
though we adjusted for major comorbidities, this information might have been incomplete, as 
the adjustments did not alter the relative risk of heart failure, leaving a risk of residual 
confounding. Moreover, other dimensions of patients’ characteristics, which lead to the 
decision to operate, remained unknown to us. These included psychological factors, fear of 
surgery, willingness to undergo a major operation, and the surgeon’s perception of the 
patient’s suitability for any of these procedures. This introduced a risk of selection bias. 
However, it would be difficult to explain the markedly lower risk in the surgical group solely 
by these methodological issues. 
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Conclusions 
 This nationwide Swedish cohort study showed that patients who underwent bariatric 
surgery had a markedly reduced risk of developing heart failure compared with non-surgical 
obese patients. The incidence rate of heart failure for a non-surgical obese patient was almost 
5 times higher than for an obese patient who underwent bariatric surgery. This suggests that 
bariatric surgery could prevent heart failure in severely obese patients. More data are needed 
on characteristics in obese persons selected for surgical or non-surgical management before a 
firm conclusion on the effectiveness of surgery for the prevention of heart failure can be 
made. 
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Figure 1. Multi-states disease model showing the absolute risk of moving from one state to 
another. 1= Obesity diagnosis to bariatric surgery, 2= Obesity diagnosis to heart failure, 3= 
Obesity diagnosis to death, 4= Bariatric surgery to heart failure, 5= Bariatric surgery to death, 
6= Survival, free of heart failure at end of study. 
 
Figure 2. Hazard ratios for risk of heart failure and mortality comparing patients with obesity 
who did and did not undergo bariatric surgery. 
 
Figure 3. Heart failure free survival by operation and non-operation.  
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Table 1. Age distribution at obesity diagnosis and comorbidities at for all at obesity 
diagnosis, among non-surgical patients at obesity diagnosis, and among surgery patients 
at date of surgery 
 Total Non-surgical Surgical  
All n=47,859 n= 25,564 n= 22,295  
(% of total) (100%) (53.4%) (46.6%)  
Age years SD 42.6±12.2 44.313.2 40.710.7  
18-44 n (%) 27,488 (57.4) 13,139 (51.4) 14,349 (64.3)  
45-54 n (%) 11,280 (23.6) 5939 (23.2) 5341 (24.0)  
55-74 n (%) 9091 (19.0) 6486 (25.4) 2605 (11.7)  
Comorbidities    p* 
Hypertension n (%) 6892 (14.4) 4557 (17.8) 4830 (21.7) <.0001 
Diabetes mellitus n (%) 4925 (10.3) 3010 (11.8) 3325 (14.9) <.0001 
Sleep apnea n (%) 3619 (7.6) 2385 (9.3) 2756 (5.8) <.0001 
Coronary heart disease n (%) 1666 (3.5) 1189 (4.7) 598 (2.7) <.0001 
Malignancy n (%) 1364 (2.9) 951 (3.7) 483 (2.2) <.0001 
Myocardial infarction n (%) 664 (1.4) 474 (1.9) 227 (1.1) <.0001 
Atrial fibrillation n (%) 571 (1.2) 419 (1.6) 238 (1.1) <.0001 
Stroke n (%) 566 (1.2) 395 (1.6) 206 (0.9) <.0001 
Valvular disease
a
 n (%) 505 (1.1) 327 (1.3) 206 (0.9) 0.0004 
Cardiomyopathy n (%) 71 (0.15) 53 (0.2) 22 (0.1) 0.0026 
SD= standard deviation. p=.05 
a 
Congenital heart disease and valve disease 
* Pearson Chi Square test for mean differences 
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Table 2.  Incidence rates for heart failure in patients with obesity who did and did not 
undergo bariatric surgery, by age group 
 Number at risk Number of 
incident cases 
Person-years Incidence rate (95 % 
CI)* 
 
Non-
surgica
l  
Surgic
al  
Non-
surgical  
Surgica
l  
Non-
surgica
l  
Surgica
l  
Non-
surgical  
Surgical  
All 25,564 22,295 944 89 137251 86008 6.9 (6.4-
7.3) 
1.0 (0.8-
1.3) 
Age 
groups 
        
   18-44 13,139 14,349 105 16 71016 57844.3 1.5 (1.2-
1.8) 
0.3 (0.1-
0.4) 
   45-49 3109 3095 77 19 16045.2 11063.4 4.8 (3.7-
5.9) 
1.7 (1.0-
2.5) 
   50-54 2830 2246 104 18 15329 8228.5 6.8 (5.5-
8.1) 
2.2 (1.2-
3.2) 
   55-59 2786 1694 182 14 16195.9 6017.5 11.2 (9.6-
12.9) 
2.3 (1.1-
3.6) 
   60-64 2053 750 204 17 10640.5 2356.6 19.2 (16.5-
21.8) 
7.2 (3.8-
10.6) 
   65-69 1095 152 162 5 5267.6 470.5 30.8 (26.0-
35.5) 
10.6 (1.3-
19.9) 
   70-74 552 9 110 0 2756.7 27 39.9 (32.5- 0.0 
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47.4) 
CI=Confidence intervals. 
* per 1000 years. 
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